A future with no barriers to building a family

Jordan trained as a doctor in the NHS and later a Schwarzman Scholar, and has dedicated his career to improving women’s health and extending reproductive longevity. He is passionate about combining science, compassion, and innovation to give more people the chance to build the families they dream of.

Chloe Charalambous has a background in reproductive cell biology and co-founded U-Ploid with a passion for advancing reproductive healthcare. She has expertise in pre-clinical research and development, and a deep understanding of the challenges and opportunities in the fertility sector.

Alex is an experienced reproductive molecular biologist. His research focuses on genome maintenance and chromosome structures in animal eggs, with special interest for bioengineering solutions supporting egg development. His previous role as a visiting scientist at the Bourn Hall Fertility Clinic (Cambridgeshire, UK) revealed to Alex the difficult journey women undertake when trying to conceive by assisted reproduction. This experience motivated him to leverage powerful molecular-based innovations to improve fertility healthcare.

Eirini Bellou is a Cell and Reproductive Biologist who has joined U-Ploid as a Senior Applications Scientist. Her scientific background spans mammalian egg research, including human eggs, as well as preimplantation embryo development. With a comprehensive understanding of the challenges within the fertility sector, Eirini is dedicated to leveraging her expertise to advance reproductive healthcare through innovation.

Hannah has joined U-Ploid as the Laboratory Manager, with experience in running GLP, GCP and GMP laboratories. Her experience also covers health and safety and quality management across large and small scale facilities. Hannah is dedicated to continuous improvement across all areas of operations and brings a deep understanding of requirements in running a safe and efficient lab.

Emily is a Research Scientist at U-Ploid with a background in reproductive biology. She holds an MSc in Clinical Embryology from the University of Oxford and a BSc from Durham University, where she also gained industry experience in the medical device sector. Emily is driven by a passion for advancing reproductive science and improving outcomes for patients.

Sarah brings over two decades of clinical research experience to U-Ploid Biotechnologies having managed and directed multi-country trials, built high-performing teams and accelerated site start-up and compliance across biotech, pharma and CRO environments. Most recently prior to joining U-Ploid, Sarah spent 3.5 years with Avillion Life Sciences in respiratory medicine and 8 years with GW Pharmaceuticals (now Jazz Pharmaceuticals) successfully working to help bring the first botanical cannabinoid to market for the treatment of two rare paediatric epilepsies.